Mostly Markets
Subscribe
Stocks/Health Care/Health Care Distributors

Henry ScheinHSIC

Health Care Distributors · Melville, New York · In the S&P 500
Cheaper than peers
$84.88−1.80%After hours: $84.88 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 36.2% over 1 year
Henry Schein over 1 yearDaily close, $, to 30 Oct 2026
$70$80$90Nov2026MarMayJulSep$84.88$80NovMarJul$84.88
Source: Nasdaq daily closes
Market value$9.46B
Price to earnings24.7x
Forward P/E15.0x
Dividend yield–
Year to date+12.3%
One year+36.2%
Next earningsTue 3 Nov, before the open
SectorHealth Care
52-week range (closes)
$62.90$90.86

Quality and valuation

How Henry Schein compares with other health care stocks. A description, not a recommendation.

Henry Schein and 5 health care distributors peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: cheaper than most

A weaker business than most health care companies, priced below most of them.

Henry Schein trades at 15.0 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +6.5% vs +7.8%
  • Keeps less of each sale (gross margin): 31.3% vs 65.3%
  • Less profitable (operating margin): 5.0% vs 13.3%
  • Turns less of its sales into cash: 4.2% vs 15.9%
HSIC trades at 15.0x forward earnings, below the sector medianForward p/e, Health Care Distributors peers
HSIC15.0xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1xHSIC15.0xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 24.8x earnings, HSIC is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x30xAverage 24.5x2025202624.8x20x30xAverage 24.5x2025202624.8x
Source: Nasdaq prices; SEC filings

Financials

From Henry Schein's SEC filings, through the quarter ending 27 Jun 2026. Hover or tap a bar for its value.

Revenue grew 6.7% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$1bn$2bn$3bnQ3 ’24Q1 ’25Q3 ’25$3.5bnQ2 ’26$0bn$2bnQ3 ’24Q1 ’25Q3 ’25$3.5bnQ2 ’26
Source: SEC filings
Growth sped up to +6.7% last quarterRevenue growth, year on year, %
0%2%4%6%Q3 ’24Q1 ’25Q3 ’256.7%Q2 ’260%5%Q3 ’24Q1 ’25Q3 ’256.7%Q2 ’26
Source: SEC filings
Operating margin was 4.9% last quarterOperating income as a share of revenue, %
0%2%4%Q3 ’24Q1 ’25Q3 ’254.9%Q2 ’260%2%4%Q3 ’24Q1 ’25Q3 ’254.9%Q2 ’26
Source: SEC filings
Free cash flow was $569 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$200mQ3 ’24Q1 ’25Q3 ’25$212mQ2 ’26$0m$200mQ3 ’24Q1 ’25Q3 ’25$212mQ2 ’26
Source: SEC filings
Last 12 monthsHSICSector median
Revenue growth+6.5%+7.8%
Gross margin31.3%65.3%
Operating margin5.0%13.3%
Free cash flow margin4.2%15.9%
Price to earnings24.7x30.2x

Stories on Henry Schein

We haven't written about Henry Schein yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Distributors, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B